Vivo Capital’s Instil Bio TIL Stock Holding History

Vivo Capital’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25M	Hold	292,743	–	–	0.21%	43
2026 Q1	$2.41M	Hold	292,743	–	–	0.2%	42
2025 Q4	$3.22M	Hold	292,743	–	–	0.21%	42
2025 Q3	$5.23M	Hold	292,743	–	–	0.42%	42
2025 Q2	$6.1M	Sell	292,743 -292,742	-50%	-$6.12M	0.62%	34
2025 Q1	$10.2M	Hold	585,485	–	–	1.35%	12
2024 Q4	$11.2M	Sell	585,485 -38,854	-6%	-$1.18M	1.25%	18
2024 Q3	$42M	Hold	624,339	–	–	3.48%	7
2024 Q2	$6.42M	Buy	624,339 +1	+0%	+$11	0.59%	29
2024 Q1	$6.74M	Sell	624,338 -2	-0%	-$22	0.53%	33
2023 Q4	$4.76M	Buy	624,340 +1	+0%	+$7	0.39%	36
2023 Q3	$5.34M	Hold	624,339	–	–	0.59%	35
2023 Q2	$6.88M	Hold	624,339	–	–	0.47%	29
2023 Q1	$8.25M	Hold	624,339	–	–	0.57%	23
2022 Q4	$7.87M	Hold	624,339	–	–	0.91%	24
2022 Q3	$60.4M	Hold	624,339	–	–	6.67%	2
2022 Q2	$57.7M	Hold	624,339	–	–	5.79%	3
2022 Q1	$134M	Hold	624,339	–	–	9.24%	3
2021 Q4	$214M	Hold	624,339	–	–	12.88%	1
2021 Q3	$223M	Hold	624,339	–	–	10.02%	2
2021 Q2	$241M	Hold	624,339	–	–	10.44%	1
2021 Q1	$313M	Buy	+624,339	New	+$320M	11.01%	1

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Vivo Capital's TIL Position: Q2 2026 in Review

Vivo Capital held its Instil Bio (TIL) position steady in Q2 2026 at 292,743 shares worth $2.25M. The position accounts for 0.21% of the portfolio, ranked #43.

Vivo Capital first reported a position in TIL in Q1 2021 and has held it in 22 quarters since. The position peaked at $313M in Q1 2021. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

Vivo Capital held 292,743 shares of Instil Bio worth $2.25M as of Q2 2026.
Vivo Capital left its Instil Bio share count unchanged in Q2 2026.
Instil Bio made up 0.21% of Vivo Capital's portfolio in Q2 2026, its #43 holding.
Vivo Capital first reported a position in Instil Bio in Q1 2021 and has held it in 22 quarters since.
Vivo Capital's Instil Bio position peaked at $313M in Q1 2021.
26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Vivo Capital's 13F filing for Q2 2026, filed 14 Aug 2026.